Jeffrey Tobias Insider Profile
4 Followers
Jeffrey Tobias, EVP, R&D & CMO at Jazz Pharmaceuticals, holds 38.48K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 10.00K shares in Neurogesx (Ticker: NGSX).
Jeffrey Tobias's Trading History
| JAZZJazz Pharmaceuticals | Mar 09, 2015 | EVP, R&D & CMO | Uninformative Sell | 284.86K | $9.30M | |
| NGSXNeurogesx | May 19, 2011 | ― | Informative Sell | 6.78K | $49.99 |
You May Also Like
Jeffrey Tobias insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Tobias?
The percentage of profitable transactions made by Jeffrey Tobias is 50%.
What is the average return per transaction made by Jeffrey Tobias?
The average return per transaction made by Jeffrey Tobias is -0.50%.
What stocks does Jeffrey Tobias hold?
Jeffrey Tobias holds: JAZZ, NGSX stocks.
What was Jeffrey Tobias’s latest transaction?
Jeffrey Tobias’s latest transaction was an Uninformative Sell of $284.86K.
What was Jeffrey Tobias's most profitable transaction?
Jeffrey Tobias’s most profitable transaction was an Informative Sell of JAZZ stock on November 25, 2014. The return on the trade was 11.70%.
What is Jeffrey Tobias's role in Jazz Pharmaceuticals?
Jeffrey Tobias's role in Jazz Pharmaceuticals is EVP, R&D & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
